Endothelial activation biomarkers increase after hiv-1 acquisition: plasma vcam-1 predicts disease progression
dc.contributor.author | Graham, Susan M. | |
dc.contributor.author | Rajwans, Nimerta | |
dc.contributor.author | Jaoko, Walter | |
dc.contributor.author | Estambale, Benson B. | |
dc.contributor.author | Mcclelland, R. Scott | |
dc.contributor.author | Overbaugh, Julie | |
dc.contributor.author | Liles, Conrad W. | |
dc.date.accessioned | 2018-07-09T11:43:15Z | |
dc.date.available | 2018-07-09T11:43:15Z | |
dc.date.issued | 2013-07-17 | |
dc.identifier.uri | https://europepmc.org/articles/pmc3883757 | |
dc.identifier.uri | http://ir.jooust.ac.ke:8080/xmlui/handle/123456789/1363 | |
dc.description | doi: 10.1097/QAD.0b013e328360e9fb | en_US |
dc.description.abstract | Objective—We aimed to determine whether endothelial activation biomarkers increase after HIV-1 acquisition, and whether biomarker levels measured in chronic infection would predict disease progression and death in HIV-1 seroconverters. | en_US |
dc.language.iso | en | en_US |
dc.publisher | PMC | en_US |
dc.subject | HIV-1 | en_US |
dc.subject | VCAM-1 | en_US |
dc.subject | ICAM-1 | en_US |
dc.subject | Angiopoietin-1 | en_US |
dc.subject | Angiopoietin-2 | en_US |
dc.subject | E-selectin | en_US |
dc.subject | Endothelial activation | en_US |
dc.title | Endothelial activation biomarkers increase after hiv-1 acquisition: plasma vcam-1 predicts disease progression | en_US |
dc.type | Article | en_US |